Navigation Links
Clinical Data Demonstrates Long-Term Safety of Boston Scientific's Alair[TM]Bronchial Thermoplasty System
Date:9/26/2011

PARIS, September 27, 2011 /PRNewswire/ --


- Five-year data from Research in Severe Asthma (RISA) Trial demonstrate maintenance of stable lung function and absence of late clinical complications

- Patients in Europe with severe asthma can now benefit from unique and proven non-drug therapy

Boston Scientific Corporation (NYSE: BSX) announces positive clinical data from the Research in Severe Asthma (RISA) Trial, demonstrating the long-term safety of bronchial thermoplasty (BT) in patients treated with the Company's Alair™ Bronchial Thermoplasty System.  Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT.  Results were presented today at the annual European Respiratory Society (ERS) Congress[1] in Amsterdam by Michel Laviolette, M.D., Professor of Medicine, Institut universitaire de cardiologie et de pneumologie at Université Laval in Québec City, Canada.

To view the Multimedia News Release, please click:

http://multivu.prnewswire.com/mnr/prne/bostonscientific/52128/

"Bronchial thermoplasty clinical data continue to support this promising therapy, which is creating real excitement in the physician community," said Dr. Laviolette, a principal investigator for the RISA Trial.  "Existing evidence suggests a significant long-term benefit, and results from the RISA Trial clearly confirm long-term safety.  BT provides us a new option for treating patients with severe asthma that can provide proven reductions in hospital visits, out-of-pocket costs and missed workdays due to asthma symptoms."

Long-term safety data from the RISA Trial are cons
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients
2. New Data Analyses from Lorcaserin Phase 3 Clinical Trials to be Presented at Obesity 2011
3. Uptake Medical Receives CE Mark for InterVapor - Endoscopic Lung Volume Reduction for Treatment of Severe Emphysema - and Announces Positive Clinical Results
4. Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339
5. AccuNurse Delivers Real-Time Care Plan Functionality and New Dashboard to Monitor Clinical Trends, Performance and Compliance
6. Marshall Edwards Announces First Patient Dosed in Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
7. Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
8. OncoGenex Announces Completion of a Special Protocol Assessment (SPA) Amendment with the FDA Increasing Patient Eligibility for the Custirsen Phase III Prostate Cancer SATURN Clinical Trial
9. Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise
10. ClinStar to Present on Russias Performance as an Emerging Market in Global Clinical Trials
11. Cempra Announces Comparable Efficacy of Oral Solithromycin (CEM-101) Compared with Levofloxacin in Phase II Clinical Trial in Patients with Community-Acquired Bacterial Pneumonia (CABP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015 ... Zwecks Leistungsvergleich zur Expertise und zum ... verwiesen, in denen uneingeschränkt betriebsfähige Systeme, ... ein Aegate-Land: beispielsweise BELGIEN   ... von Arzneimittelfälschungen (FMD) handelt es sich ...
(Date:5/21/2015)... 21, 2015  Today, eight groups representing ... biologics – Alliance for Patient Access, American ... Rheumatology, Biologics Prescribers Collaborative, Clinical Immunology Society, ... and North American Society for Pediatric Gastroenterology, ... to U.S. Food and Drug Administration (FDA) ...
(Date:5/21/2015)... 2015 Bankers Healthcare Group, the leading provider of ... series from medical writer Dr. Pat Bass on ... analyze the decision making process, uncover various preconceived notions that ... how healthcare practitioners can make better, more profitable decisions. ... 7, 2015: " Being More Decisive: You,ve Got To Make ...
Breaking Medicine Technology:EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 2Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 3Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 4Medical Writer Dr. Pat Bass Publishes A New Series On The Bankers Healthcare Group BHG360 Blog 2Medical Writer Dr. Pat Bass Publishes A New Series On The Bankers Healthcare Group BHG360 Blog 3
(Date:5/22/2015)... Co founders Greenlee and James Chapko, DDS have launched ... immediately deliver fully integrated dental implant services to their patients. ... surgeon. , The Center, whose name is ImplantWide, ... placing dental implants. These 6 roadblocks can discourage any ... placement of dental implants into his or her practice. ...
(Date:5/22/2015)... 22, 2015 Puritan Medical Products, ... the medical, diagnostic, environmental, and forensics industries celebrates ... products in the US. At a time when ... the US, Puritan remains committed to designing and ... Guilford, Maine facility. , Since 1919, Puritan has ...
(Date:5/22/2015)... WI (PRWEB) May 22, 2015 ... honor to be recognized for providing the highest quality ... foundation of health care decision-making,” said Javon R. Bea, ... demonstrates the commitment of our employee/partners to care for ... patients.” , Hospitals do not apply for this award, ...
(Date:5/21/2015)... York, New York (PRWEB) May 21, 2015 ... distributor of patented products, launches the Troll Motor Guide, ... convenient way of boating. , "The recreational boating industry ... Scott J. Cooper, CEO and Creative Director of ... water in record numbers and predicts continued steady growth ...
(Date:5/21/2015)... 2015 Absolute Exhibits, a trade ... state-of-the-art website that is filled with essential exhibiting tools ... information. With its original and inventive design ideas, it ... website shows hundred of pictures of client- owned or ... is not an exhibit rendering site, rather real-time pictures ...
Breaking Medicine News(10 mins):Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:New Convention and City Travel Guides Within the Absolute Exhibits’ Website 2
... infants' exposure to tobacco smoke. Infant exposure to environmental ... syndrome, asthma, and other respiratory conditions. ,A recent study ... of 314 infants living in smoking households. Participating infants ... from the University of Warwick, United Kingdom, found banning ...
... believed to be Britain's first genetically-selected baby after receiving ... baby, named Jamie, was delivered by Caesarean section on ... embryo, to his four-year-old brother Charlie. Charlie has a ... the United States for treatment after being refused permission ...
... Researchers say 85 percent to 90 percent of the people ... fatigue, muscle pain, insomnia and impaired memory. ,It's a difficult ... 1.3 million Americans who suffer from chronic fatigue syndrome, or ... may help them get back a bit of their former ...
... double the risk of an older person developing serious ... independently. Researchers say seniors who do not have anemia, ... cut-off point for the condition's diagnosis, are 1.5-times more ... normal blood hemoglobin levels.// ,Investigators followed 1,146 people, ...
... If you're looking to lower your cholesterol, eating a ... shows a diet that consists of healthy foods, including ... certain drugs. ,Researchers say incorporating almonds into one's diet ... substitutions to try might include a snack of almonds ...
... A new test may be an important tool in ... Clinical Electroencephalography highlights the use of an electrical brain ... to improved treatment. The test, known as an electrophysiological ... the disease.// ,Researchers found 65 percent of patients with ...
Cached Medicine News:
... the easiest test to use on the market. ... no hands-on time. Critical care instructions can be ... the pediatrician's office. Valuable information can be obtained ... Now the focus can be on the results ...
The QuickScreen Pro Multi Drug Screening Test is a rapid, self-timing, qualitative immunoassay for,the detection of drugs of abuse in urine....
... qualitative immunoassays for detecting elevated levels of Luteinizing ... and results are easy to interpret. If ... the control band, then ovulation will probably occur ... test band does not appear or is lighter ...
Detect LH surge for predicting ovulation, Able to detect as low as 40 mIU/mL LH or 30 mIU/mL LH, Simple, easy and accurate, Built-in control system...
Medicine Products: